Thermo Fisher Scientific Inc. (NYSE:TMO) Stock Holdings Reduced by Montag & Caldwell LLC

Montag & Caldwell LLC decreased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.3% during the second quarter, HoldingsChannel reports. The firm owned 322,892 shares of the medical research company’s stock after selling 11,057 shares during the period. Thermo Fisher Scientific comprises 4.9% of Montag & Caldwell LLC’s portfolio, making the stock its 3rd largest holding. Montag & Caldwell LLC’s holdings in Thermo Fisher Scientific were worth $94,827,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Eagle Ridge Investment Management purchased a new position in shares of Thermo Fisher Scientific in the 2nd quarter worth approximately $212,000. Watch Point Trust Co grew its position in shares of Thermo Fisher Scientific by 34.9% in the 2nd quarter. Watch Point Trust Co now owns 9,784 shares of the medical research company’s stock worth $2,873,000 after buying an additional 2,531 shares during the last quarter. TRUE Private Wealth Advisors purchased a new position in shares of Thermo Fisher Scientific in the 2nd quarter worth approximately $119,000. Lyell Wealth Management LP grew its position in shares of Thermo Fisher Scientific by 4.9% in the 2nd quarter. Lyell Wealth Management LP now owns 19,893 shares of the medical research company’s stock worth $5,846,000 after buying an additional 922 shares during the last quarter. Finally, Voit & Company LLC grew its position in shares of Thermo Fisher Scientific by 4.4% in the 2nd quarter. Voit & Company LLC now owns 10,649 shares of the medical research company’s stock worth $3,127,000 after buying an additional 445 shares during the last quarter. 88.21% of the stock is currently owned by institutional investors and hedge funds.

A number of research analysts have recently issued reports on TMO shares. Wolfe Research started coverage on shares of Thermo Fisher Scientific in a research report on Thursday, May 30th. They issued an “outperform” rating on the stock. Credit Suisse Group reaffirmed a “buy” rating and issued a $310.00 price objective on shares of Thermo Fisher Scientific in a research report on Wednesday, July 31st. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $299.00 price objective on the stock in a research report on Wednesday, June 12th. Needham & Company LLC lifted their price objective on shares of Thermo Fisher Scientific from $315.00 to $321.00 and gave the stock a “buy” rating in a research report on Thursday, July 25th. Finally, Argus lifted their price objective on shares of Thermo Fisher Scientific from $285.00 to $310.00 and gave the stock a “buy” rating in a research report on Wednesday, May 1st. Two investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $303.17.

TMO stock traded up $3.86 during trading on Thursday, reaching $273.34. The company had a trading volume of 51,785 shares, compared to its average volume of 1,592,969. The business has a 50-day simple moving average of $287.70. The firm has a market cap of $108.93 billion, a P/E ratio of 24.54, a price-to-earnings-growth ratio of 1.78 and a beta of 1.11. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.07 and a current ratio of 1.49. Thermo Fisher Scientific Inc. has a twelve month low of $208.34 and a twelve month high of $305.45.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, July 24th. The medical research company reported $3.04 EPS for the quarter, topping analysts’ consensus estimates of $3.01 by $0.03. The company had revenue of $6.32 billion during the quarter, compared to analysts’ expectations of $6.31 billion. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.11%. Thermo Fisher Scientific’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same period last year, the business earned $2.75 EPS. As a group, analysts expect that Thermo Fisher Scientific Inc. will post 12.24 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, September 17th will be paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date is Monday, September 16th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is presently 6.83%.

In related news, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $284.83, for a total value of $14,241,500.00. Following the completion of the sale, the chief executive officer now directly owns 342,193 shares in the company, valued at approximately $97,466,832.19. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director C Martin Harris sold 275 shares of Thermo Fisher Scientific stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $270.73, for a total transaction of $74,450.75. Following the completion of the sale, the director now owns 6,433 shares of the company’s stock, valued at $1,741,606.09. The disclosure for this sale can be found here. Insiders sold a total of 52,775 shares of company stock valued at $14,986,676 over the last quarter. 0.45% of the stock is owned by company insiders.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

See Also: What is the Gross Domestic Product (GDP)?

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.